PF-Atlas › Clinical Trials › NCT04540770
A Phase 1 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Immunogenicity of HuL001
HuL001 · Phase 1
Registry ID
NCT04540770
Phase
Phase 1
Status
Completed
Drug / intervention
HuL001
Sponsor
HuniLife Biotechnology, Inc.
Start
2021-08-31
About this trial
HuL001 is evaluated in NCT04540770, a Phase 1 idiopathic pulmonary fibrosis study sponsored by HuniLife Biotechnology, Inc.. Current status: Completed.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04540770 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.